Transition metal complexes: a new generation of anticancer drugs
Artículo
Acceso abierto
Artículo
CONICET Digital
The interest in transition metal complexes as antitumor agents started in the 1960s with the serendipitous dis- covery of cisplatin. This drug was appr ov ed by the US FDA in the 1970s for its use as a chemotherapeutic a...
Idioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access